WAC

2

Review clinical trials related to WAC. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders and may be associated with autism. Simons Searchlight collects medical, behavioral, learning, and developmental information from people who have these rare genetic changes. The goal of this study is to improve the clinical care and treatment for these people. Simons Searchlight partners with families to collect data and distribute it to qualified researchers.

Participants needed: 100,000
Trial details
Biological sex: AllType: ObservationalSponsor: Simons SearchlightUpdated: Jun 6, 2025Locations: 2
Eligibility criteria

Subjects of any age with a genetic condition on our eligible list along with the... [+3]

Status: Recruiting

Further Delineation of the De Santo Shinawi Syndrome Phenotype Using a Series of Individuals Carrying a Pathogenic Variant of the WAC Gene

The aim of this retrospective, multicenter study would be to extend the phenotypic spectrum of DeSanto Shinawi Syndrome and improve the knowledge of its evolution. To this end, the investigators would like to issue a call for international collaboration in order to create a series of new genetically diagnosed patients, not yet described in previous publications, and with a larger number of individuals evaluated in a single study. One of the aims would be to establish a set of standardized clinical and paraclinical examinations to be carried out at diagnosis and for follow-up of affected patients. This would enable patients, their families and the caregivers involved to better anticipate future management.

Participants needed: 50
Trial details
Biological sex: AllType: ObservationalSponsor: University Hospital, Clermont-FerrandUpdated: Feb 4, 2025Locations: 1
Eligibility criteria

Children and adults of any age. [+1]

Patients with a molecular diagnosis of another VP (SNV) of a gene responsible fo... [+2]